ZA974216B - Process for the resolution of racemic ketamine. - Google Patents

Process for the resolution of racemic ketamine.

Info

Publication number
ZA974216B
ZA974216B ZA9704216A ZA974216A ZA974216B ZA 974216 B ZA974216 B ZA 974216B ZA 9704216 A ZA9704216 A ZA 9704216A ZA 974216 A ZA974216 A ZA 974216A ZA 974216 B ZA974216 B ZA 974216B
Authority
ZA
South Africa
Prior art keywords
resolution
pct
racemic ketamine
date nov
ketamine
Prior art date
Application number
ZA9704216A
Other languages
English (en)
Inventor
Klaus Steiner
Stefan Gangkofner
Jean-Marie Grunenwald
Original Assignee
Uetikon Chemie Gmbh
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uetikon Chemie Gmbh, Goedecke Ag filed Critical Uetikon Chemie Gmbh
Publication of ZA974216B publication Critical patent/ZA974216B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/20Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA9704216A 1996-05-15 1997-05-15 Process for the resolution of racemic ketamine. ZA974216B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19619665A DE19619665C2 (de) 1996-05-15 1996-05-15 Racemattrennung von Ketamin

Publications (1)

Publication Number Publication Date
ZA974216B true ZA974216B (en) 1997-12-10

Family

ID=7794445

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704216A ZA974216B (en) 1996-05-15 1997-05-15 Process for the resolution of racemic ketamine.

Country Status (20)

Country Link
US (1) US6040479A (cs)
EP (1) EP0918744B1 (cs)
JP (1) JP4151988B2 (cs)
AT (1) ATE272606T1 (cs)
AU (1) AU727528B2 (cs)
CA (1) CA2253575C (cs)
CZ (1) CZ293546B6 (cs)
DE (2) DE19619665C2 (cs)
DK (1) DK0918744T3 (cs)
EE (1) EE03436B1 (cs)
ES (1) ES2224247T3 (cs)
HU (1) HU225773B1 (cs)
IL (1) IL127026A (cs)
NO (1) NO311565B1 (cs)
PL (1) PL187625B1 (cs)
PT (1) PT918744E (cs)
SK (1) SK282699B6 (cs)
TR (1) TR199802317T2 (cs)
WO (1) WO1997043244A1 (cs)
ZA (1) ZA974216B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0002693B8 (pt) * 2000-06-19 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda processo de obtenção dos enantiômeros da cetamina e seus sais farmaceuticamente aceitáveis
SG10201802104QA (en) 2013-03-15 2018-05-30 Janssen Pharmaceutica Nv Pharmaceutical composition of s-ketamine hydrochloride
US9872841B2 (en) 2013-09-13 2018-01-23 National University Corporation Chiba University Application of R-ketamine and salt thereof as pharmaceuticals
KR20170040800A (ko) 2014-08-13 2017-04-13 얀센 파마슈티카 엔.브이. 우울증 치료 방법
KR20170054470A (ko) 2014-09-15 2017-05-17 얀센 파마슈티카 엔.브이. VAL66MET (SNP rs6265) 유전자형 특이적 투여 계획 및 우울증 치료 방법
US20160332962A1 (en) * 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
CA3041275A1 (en) 2016-10-27 2018-05-03 National University Corporation Chiba University Pharmaceutical applications for (s)-norketamine and salts thereof
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
TW201919595A (zh) 2017-09-27 2019-06-01 國立大學法人千葉大學 作為神經變性疾病或認知機能障礙之預防或治療劑之r-氯胺酮及其衍生物
SG11202005896WA (en) 2017-12-22 2020-07-29 Janssen Pharmaceuticals Inc Esketamine for the treatment of depression
CN111936127A (zh) 2018-02-15 2020-11-13 国立大学法人千叶大学 炎症性疾病或骨病的预防或治疗剂及医药组合物
JP2021523228A (ja) 2018-05-04 2021-09-02 パーセプション ニューロサイエンス,インコーポレイティド 物質乱用の治療方法
US20220110889A1 (en) 2018-12-27 2022-04-14 National University Corporation Chiba University R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodevelopmental disorder
EP3934632A4 (en) 2019-03-05 2022-11-23 Janssen Pharmaceuticals, Inc. Esketamine for the treatment of depression
WO2020212510A1 (en) * 2019-04-16 2020-10-22 Janssen Pharmaceutica Nv Synthetic methods of preparing esketamine
CN112409195A (zh) * 2020-03-17 2021-02-26 国药集团工业有限公司 一种(s)-氯胺酮盐酸盐的制备方法及其中间体、其晶型
CN112125816A (zh) * 2020-03-17 2020-12-25 国药集团工业有限公司 一种氯胺酮、其衍生物或其盐的消旋化方法
WO2024145288A2 (en) * 2022-12-28 2024-07-04 Perception Neuroscience, Inc. Methods of administering r-ketamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH535201A (de) * 1969-12-19 1973-03-31 Bristol Myers Co Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren

Also Published As

Publication number Publication date
IL127026A0 (en) 1999-09-22
DE19619665A1 (de) 1997-11-20
EP0918744B1 (de) 2004-08-04
PL329743A1 (en) 1999-04-12
EP0918744A1 (de) 1999-06-02
JP2000510135A (ja) 2000-08-08
NO985300D0 (no) 1998-11-13
PT918744E (pt) 2004-10-29
TR199802317T2 (xx) 1999-02-22
ATE272606T1 (de) 2004-08-15
NO985300L (no) 1998-11-13
ES2224247T3 (es) 2005-03-01
HUP9903085A3 (en) 2000-05-29
CZ355898A3 (cs) 1999-04-14
CA2253575C (en) 2005-11-29
DE19619665C2 (de) 2001-03-08
JP4151988B2 (ja) 2008-09-17
HUP9903085A1 (hu) 2000-04-28
AU727528B2 (en) 2000-12-14
PL187625B1 (pl) 2004-08-31
NO311565B1 (no) 2001-12-10
DE59711834D1 (de) 2004-09-09
AU2894397A (en) 1997-12-05
DK0918744T3 (da) 2004-12-06
SK152998A3 (en) 1999-07-12
CZ293546B6 (cs) 2004-06-16
HU225773B1 (en) 2007-08-28
CA2253575A1 (en) 1997-11-20
WO1997043244A1 (de) 1997-11-20
EE9800394A (et) 1999-06-15
SK282699B6 (sk) 2002-11-06
IL127026A (en) 2004-02-19
US6040479A (en) 2000-03-21
EE03436B1 (et) 2001-06-15

Similar Documents

Publication Publication Date Title
IL127026A0 (en) Process for the resolution of racemic ketamine
AU3092997A (en) Thermosetting, aqueous compositions
ATE219064T1 (de) Piperazinderivative als tachykinin antagonisten
AU2093797A (en) Wood preservative for afterprotection
DE69710182D1 (de) Verwendung von tetrahydrobetacarbolin-derivaten zur vorbeugung der metastasenbildung
AU5320698A (en) Substituted dihydrobenzofurans as pde inhibitors
AU1719797A (en) Process for the preparation of 2,2'-bipyrrolyl-pyrromethene (prodigiosins) derivatives
SG141217A1 (en) Non-homogeneous systems for the resolution of enantiomeric mixtures
NO991633D0 (no) FremgangsmÕte ved biotransformasjon av kolkisinforbindelser til de tilsvarende 3-glykosyl-derivater
SE9600086D0 (sv) New manufacturing process
DE69712878D1 (en) Phosphatasemodulator
CA2322501A1 (en) Processes for the preparation of (r)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
AU6117198A (en) Method for managing an operation of iron carbide producing process
AU3055397A (en) Heterocyclic compounds
ES2154457T3 (es) Derivados de ciclohexadieno sustituidos con dimetilo.
EP0859758A4 (cs)
ATE209493T1 (de) Verwendung von aspirochlorine oder dessen derivaten zur immunsuppression